Developing more predictive preclinical tools to better reach proof of concept.

Scope: novel pre-clinical models with high predictive value, including new screening technologies for toxicity or efficacy, novel models predictive of biodistribution Examples: Standardized drug sensitivity screening tests using patient derived material.

For more information visit the conference website.